ArticleEuropean journal of medical research2025
Systolic blood pressure time in target range within 24 h and in-hospital death of critically ill patients and the role of ventricular arrhythmias: a MIMIC-IV analysis with external validation in the eICU-CRD database.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe stability of blood pressure control is crucial in critically ill patients. Systolic blood pressure (SBP) time in target range (TTR) has been recognized as an emerging dynamic assessment indicator of blood pressure, but its prognostic value in critically ill patients remains unclear.
methodsThis retrospective cohort study utilized data from the MIMIC-IV database, including adult patients with their first intensive care unit (ICU) admission. SBP TTR within 110-140 mmHg during the first 24 h was calculated. The primary outcome was in-hospital all-cause mortality, and the secondary outcome was ventricular arrhythmias (VA, including FPVCs, VT, and VF). Logistic regression, restricted cubic splines, subgroup analyses, receiver operating characteristic (ROC) curve analyses, and Karlson-Holm-Breen mediation analysis were performed. Furthermore, the findings were externally validated using the multicenter eICU-CRD database.
resultsA total of 42,648 patients were included in the primary analysis. Higher SBP TTR was significantly associated with lower in-hospital all-cause mortality (adjusted OR 0.94 per 10% increase, 95% CI 0.93-0.95) and reduced risk of VA (adjusted OR 0.97 per 10% increase, 95% CI 0.95-0.98). When compared with the lowest quartile, patients in the highest SBP TTR quartile demonstrated the lowest risk of in-hospital all-cause mortality (OR 0.66) and VA (OR 0.78). Mediation analysis suggested that VA mediated a small proportion (1.96%) of the effect of SBP TTR on in-hospital all-cause mortality. Furthermore, SBP TTR provided prognostic information independent of SBP coefficient of variation, and combining both metrics improved predictive accuracy (AUC = 0.62). Finally, the association between SBP TTR and the primary outcome (in-hospital all-cause mortality) was successfully validated in the multicenter eICU-CRD cohort (n = 55,155).
conclusionsHigher SBP TTR (110-140 mmHg) during the first 24 h of ICU admission was independently and inversely associated with in-hospital mortality and ventricular arrhythmias. This metric provides information complementary to blood pressure variability. The association with in-hospital mortality was consistently validated in the multicenter eICU-CRD database, suggesting SBP TTR may serve as a useful biomarker for risk stratification in ICU patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.